The purpose of this project is to understand the regulation of TGF-Betas by members of the steroid hormone superfamily. Studies with mouse keratinocytes have demonstrated that retinoids increased TGF-82 mRNA and protein at a post-transcriptional level, while having little effect on TGF-Beta1 expression. Anti-estrogens increased translation of TGF-Beta1 in human fibroblasts, and the progestin analog, gestodene, increased TGF-Beta1 expression at both transcriptional and post-transcriptional levels in a breast carcinoma cell line. In mouse keratinocytes and the breast carcinoma cell line, increased levels of TGF-Beta were correlated with suppression of cell growth. Furthermore, the growth inhibitory effects of retinoids and gestodene were reversed by neutralizing antibodies against TGF-Beta. These studies have demonstrated that the action of steroids on the expression of TGF-Beta are distinct and specific for the various types of TGF-Beta. Moreover, the increase in expression of TGF-Betas in response to members of the steroid hormone superfamily suggest that steroids may be useful as chemoprevention agents.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01CP005623-01
Application #
3874765
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Division of Cancer Epidemiology and Genetics
Department
Type
DUNS #
City
State
Country
United States
Zip Code